Ernexa Therapeutics (ERNA) EBITDA (2010 - 2026)
Ernexa Therapeutics' EBITDA was -$4.1 million in Q2 2026, compared with -$2.48 million a year earlier.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) EBITDA (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ernexa Therapeutics' EBITDA was -$13.73 million through Jun 30, 2026; for FY2025, it came in at -$9.25 million.
- In earlier years, EBITDA was -$15.54 million in FY2024, -$21.05 million in FY2023, -$33.06 million in FY2022 and -$113.62 million in FY2021.
- Quarterly EBITDA has moved between -$86.25 million (Q3 2021) and -$1.98 million (Q3 2025) over five years.
- Per Business Quant data, ERNA's EBITDA in the three quarters before Q2 2026 was -$5.58 million (Q1 2026), -$2.08 million (Q4 2025) and -$1.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Ernexa Therapeutics | 2.45 Mn | -16.70 Mn | - | -4.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.10 Mn |
| Mar 31, 2026 | -5.58 Mn |
| Dec 31, 2025 | -2.08 Mn |
| Sep 30, 2025 | -1.98 Mn |
| Jun 30, 2025 | -2.48 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Dec 31, 2024 | 433,000.00 |
| Sep 30, 2024 | -993,000.00 |
| Jun 30, 2024 | -4.41 Mn |
| Mar 31, 2024 | -5.30 Mn |
| Dec 31, 2023 | -5.49 Mn |
| Sep 30, 2023 | -5.49 Mn |
| Jun 30, 2023 | -4.53 Mn |
| Mar 31, 2023 | -5.30 Mn |
| Dec 31, 2022 | -4.72 Mn |
| Sep 30, 2022 | -8.26 Mn |
| Jun 30, 2022 | -13.81 Mn |
| Mar 31, 2022 | -6.26 Mn |
| Dec 31, 2021 | -8.50 Mn |
| Sep 30, 2021 | -86.25 Mn |
API Access
Ernexa Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();